oxybutynin has been researched along with Autoimmune Diabetes in 17 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
| Excerpt | Relevance | Reference |
|---|---|---|
| "G-Pump glucagon effectively increased blood glucose levels in a dose-dependent fashion with a glucose Cmax of 183, 200, and 210 mg/dL at doses of 0." | 2.82 | Comparative Pharmacokinetic/Pharmacodynamic Study of Liquid Stable Glucagon Versus Lyophilized Glucagon in Type 1 Diabetes Subjects. ( Branigan, D; Castle, JR; Cummins, M; Newswanger, B; Prestrelski, S; Shi, L; Strange, P; Youssef, JE, 2016) |
| "Twenty patients with type 1 diabetes came in for two blocks of visits: one block of two visits while wearing the OmniPod® (Insulet Corp." | 2.78 | Patch pump versus conventional pump: postprandial glycemic excursions and the influence of wear time. ( Arnolds, S; Avogaro, A; Benesch, C; Bruttomesso, D; DeVries, JH; Farret, A; Heinemann, L; Luijf, YM; Place, J; Renard, E; Scotton, R, 2013) |
| "Hypoglycemia is a serious and potentially fatal complication experienced by people with insulin-dependent diabetes." | 1.72 | Transdermal delivery of a somatostatin receptor type 2 antagonist using microneedle patch technology for hypoglycemia prevention. ( GhavamiNejad, A; Giacca, A; Liu, JF; Lu, B; Mirzaie, S; Pereira, S; Samarikhalaj, M; Wu, XY; Zhou, L, 2022) |
| "We describe a patient with type 1 diabetes mellitus complicated by retinopathy, nephropathy and neuropathy." | 1.31 | Gustatory sweating and diabetes. ( Sinnige, HA; van den Dorpel, MA; van der Linden, J, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (5.88) | 29.6817 |
| 2010's | 13 (76.47) | 24.3611 |
| 2020's | 3 (17.65) | 2.80 |
| Authors | Studies |
|---|---|
| van der Linden, J | 1 |
| Sinnige, HA | 1 |
| van den Dorpel, MA | 1 |
| Ulbrich, S | 1 |
| Waldenmaier, D | 3 |
| Haug, C | 2 |
| Freckmann, G | 3 |
| Rendschmidt, T | 1 |
| Künsting, T | 1 |
| Wang, Z | 1 |
| Wang, J | 2 |
| Li, H | 1 |
| Yu, J | 3 |
| Chen, G | 2 |
| Kahkoska, AR | 2 |
| Wu, V | 1 |
| Zeng, Y | 1 |
| Wen, D | 1 |
| Miedema, JR | 1 |
| Buse, JB | 2 |
| Gu, Z | 3 |
| GhavamiNejad, A | 2 |
| Lu, B | 2 |
| Samarikhalaj, M | 1 |
| Liu, JF | 1 |
| Mirzaie, S | 1 |
| Pereira, S | 1 |
| Zhou, L | 2 |
| Giacca, A | 2 |
| Wu, XY | 2 |
| Ye, Y | 1 |
| Zhang, X | 1 |
| Wang, C | 1 |
| Sun, W | 1 |
| Corder, RD | 1 |
| Chen, Z | 1 |
| Khan, SA | 1 |
| Payne, FW | 1 |
| Ledden, B | 1 |
| Lamps, G | 1 |
| Kamecke, U | 1 |
| Ziegler, R | 2 |
| Ginsberg, BH | 1 |
| Heinemann, L | 2 |
| Kulzer, B | 1 |
| Ginsberg, B | 1 |
| Thompson, B | 1 |
| Cook, CB | 1 |
| Li, J | 1 |
| Lam, L | 1 |
| Luijf, YM | 1 |
| Arnolds, S | 1 |
| Avogaro, A | 1 |
| Benesch, C | 1 |
| Bruttomesso, D | 1 |
| Farret, A | 1 |
| Place, J | 1 |
| Renard, E | 2 |
| Scotton, R | 1 |
| DeVries, JH | 1 |
| Borot, S | 1 |
| Franc, S | 1 |
| Cristante, J | 1 |
| Penfornis, A | 1 |
| Benhamou, PY | 1 |
| Guerci, B | 1 |
| Hanaire, H | 1 |
| Reznik, Y | 1 |
| Simon, C | 1 |
| Charpentier, G | 1 |
| Harrington, M | 1 |
| Castle, JR | 1 |
| Youssef, JE | 1 |
| Branigan, D | 1 |
| Newswanger, B | 1 |
| Strange, P | 1 |
| Cummins, M | 1 |
| Shi, L | 1 |
| Prestrelski, S | 1 |
| Sibiya, N | 1 |
| Ngubane, P | 1 |
| Mabandla, M | 1 |
3 reviews available for oxybutynin and Autoimmune Diabetes
| Article | Year |
|---|---|
Glucose-Responsive Microneedle Patches for Diabetes Treatment.
Topics: Animals; Blood Glucose; Blood Glucose Self-Monitoring; Diabetes Mellitus, Type 1; Diabetes Mellitus, | 2019 |
Patch Pumps for Insulin.
Topics: Blood Glucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Equipment Design; Humans; Hypog | 2019 |
Patch Pumps: Are They All the Same?
Topics: Blood Glucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Equipment Design; Humans; Hypog | 2019 |
3 trials available for oxybutynin and Autoimmune Diabetes
| Article | Year |
|---|---|
Patch pump versus conventional pump: postprandial glycemic excursions and the influence of wear time.
Topics: Administration, Cutaneous; Blood Glucose; Cross-Over Studies; Diabetes Mellitus, Type 1; Drug Delive | 2013 |
Accuracy of a new patch pump based on a microelectromechanical system (MEMS) compared to other commercially available insulin pumps: results of the first in vitro and in vivo studies.
Topics: Adult; Diabetes Mellitus, Type 1; Female; Humans; Hypoglycemic Agents; In Vitro Techniques; Insulin; | 2014 |
Comparative Pharmacokinetic/Pharmacodynamic Study of Liquid Stable Glucagon Versus Lyophilized Glucagon in Type 1 Diabetes Subjects.
Topics: Adult; Blood Glucose; Cross-Over Studies; Diabetes Mellitus, Type 1; Double-Blind Method; Female; Ga | 2016 |
11 other studies available for oxybutynin and Autoimmune Diabetes
| Article | Year |
|---|---|
Gustatory sweating and diabetes.
Topics: Adult; Cholinergic Antagonists; Diabetes Mellitus, Type 1; Diabetic Neuropathies; Female; Humans; Ma | 2000 |
Concept and Implementation of a Novel Patch Pump for Insulin Delivery.
Topics: Blood Glucose; Blood Glucose Self-Monitoring; Diabetes Mellitus, Type 1; Equipment Design; Glycated | 2020 |
Dual self-regulated delivery of insulin and glucagon by a hybrid patch.
Topics: Animals; Blood Glucose; Delayed-Action Preparations; Diabetes Mellitus, Experimental; Diabetes Melli | 2020 |
Transdermal delivery of a somatostatin receptor type 2 antagonist using microneedle patch technology for hypoglycemia prevention.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Drug Delivery Sy | 2022 |
Core-Shell Microneedle Gel for Self-Regulated Insulin Delivery.
Topics: Animals; Blood Glucose; Delayed-Action Preparations; Diabetes Mellitus, Type 1; Drug Delivery System | 2018 |
Capabilities of Next-Generation Patch Pump: Improved Precision, Instant Occlusion Detection, and Dual-Hormone Therapy.
Topics: Algorithms; Blood Glucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Electrochemistry; E | 2019 |
Establishing Methods to Determine Clinically Relevant Bolus and Basal Rate Delivery Accuracy of Insulin Pumps.
Topics: Blood Glucose; Circadian Rhythm; Diabetes Mellitus, Type 1; Drug Administration Schedule; Equipment | 2019 |
Insulin Pumping Patches: Emerging Insulin Delivery Systems.
Topics: Clinical Trials as Topic; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Equipment Design; Hu | 2019 |
Glucose-Responsive Composite Microneedle Patch for Hypoglycemia-Triggered Delivery of Native Glucagon.
Topics: Animals; Blood Glucose; Cross-Linking Reagents; Diabetes Mellitus, Experimental; Diabetes Mellitus, | 2019 |
A patch that fixes insulin delivery.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Type 1; Humans; Insulin; Mice; Transdermal Patch | 2015 |
Cardioprotective effects of pectin-insulin patch in streptozotocin-induced diabetic rats.
Topics: Animals; Blood Glucose; Blood Pressure; C-Reactive Protein; Cardiotonic Agents; Diabetes Mellitus, E | 2017 |